Status:

COMPLETED

Intravascular Access in Suspected/Confirmed COVID-19 Patient

Lead Sponsor:

Lazarski University

Collaborating Sponsors:

Poznan University of Medical Sciences

Medical University of Bialystok

Conditions:

Emergency Medicine

Cardiopulmonary Arrest

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The current COVID-19 pandemic, this is especially since the transmission of SARS-CoV-2 is thought to occur mainly through respiratory droplets generated by coughing and sneezing, by direct contact wit...

Eligibility Criteria

Inclusion

  • Out-of-hospital cardiac arrest (OHCA)
  • Adult ≥ 18 years old
  • Non-traumatic cause of cardiac arrest

Exclusion

  • Existing do-not-attempt-resuscitation order
  • OHCA patients with contraindications to IO access or IV access
  • Patients with signs of obvious death, e.g. rigor mortis

Key Trial Info

Start Date :

April 14 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 30 2020

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04366947

Start Date

April 14 2020

End Date

October 30 2020

Last Update

December 19 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Lazarsku University

Warsaw, Masovian Voivodeship, Poland, 02-662